In response to an absence of studies among refugees and host communities accessing highly active antiretroviral therapy (HAART) in urban settings, our objective was to compare adherence and virological outcomes among clients attending a public clinic in Kuala Lumpur, Malaysia. A cross-sectional survey was conducted among adult clients (≥18 years). Data sources included a structured questionnaire that measured self-reported adherence, a pharmacy-based measure of HAART prescription refills over the previous 24 months, and HIV viral loads. The primary outcome was unsuppressed viral load (≥40 copies/mL). Among a sample of 153 refugees and 148 host community clients, refugees were younger (median age 35 [interquartile range, IQR 31, 39] vs 40 ye...
Migrants, particularly from low- and middle-income countries, are at a heightened risk of adverse HI...
International audienceOBJECTIVES:: Benefits from HAART may be heterogeneous across people living wit...
Improving access to human immunodeficiency virus (HIV) testing and treatment is at the core of a glo...
In response to a major gap in evidence regarding treatment outcomes among asylum-based refugees. the...
UNLABELLED: BACKGROUND: Optimal adherence to highly active antiretroviral therapy (HAART) is requir...
Abstract Background Optimal adherence to highly active antiretroviral therapy (HAART) is required to...
BACKGROUND: Refugees and host nationals who accessed antiretroviral therapy (ART) in a remote refuge...
Available evidence suggests that refugees and internally displaced persons (IDPs) in stable settings...
Background: HIV-infected refugees resettled in the United States face many challenges. Longitudinal ...
Background: Refugees living with HIV in sub-Saharan Africa suffer unique hardships that may increase...
Abstract Background Refugees and host nationals who accessed antiretroviral therapy (ART) in a remot...
Purpose of review Health policy makers aspire to achieve an HIV treatment ‘cascade’ in which diagno...
SummaryObjectivesThe number of HIV-infected refugees entering the USA is increasing. There is little...
We evaluated the feasibility and efficacy of four existing interventions to improve adherence to the...
We evaluated the feasibility and efficacy of four existing interventions to improve adherence to the...
Migrants, particularly from low- and middle-income countries, are at a heightened risk of adverse HI...
International audienceOBJECTIVES:: Benefits from HAART may be heterogeneous across people living wit...
Improving access to human immunodeficiency virus (HIV) testing and treatment is at the core of a glo...
In response to a major gap in evidence regarding treatment outcomes among asylum-based refugees. the...
UNLABELLED: BACKGROUND: Optimal adherence to highly active antiretroviral therapy (HAART) is requir...
Abstract Background Optimal adherence to highly active antiretroviral therapy (HAART) is required to...
BACKGROUND: Refugees and host nationals who accessed antiretroviral therapy (ART) in a remote refuge...
Available evidence suggests that refugees and internally displaced persons (IDPs) in stable settings...
Background: HIV-infected refugees resettled in the United States face many challenges. Longitudinal ...
Background: Refugees living with HIV in sub-Saharan Africa suffer unique hardships that may increase...
Abstract Background Refugees and host nationals who accessed antiretroviral therapy (ART) in a remot...
Purpose of review Health policy makers aspire to achieve an HIV treatment ‘cascade’ in which diagno...
SummaryObjectivesThe number of HIV-infected refugees entering the USA is increasing. There is little...
We evaluated the feasibility and efficacy of four existing interventions to improve adherence to the...
We evaluated the feasibility and efficacy of four existing interventions to improve adherence to the...
Migrants, particularly from low- and middle-income countries, are at a heightened risk of adverse HI...
International audienceOBJECTIVES:: Benefits from HAART may be heterogeneous across people living wit...
Improving access to human immunodeficiency virus (HIV) testing and treatment is at the core of a glo...